About
Please Note: Due to audio issues we are re-recording a portion of this webinar prior to on-demand publication. In the meantime, you can continue to register, and will be notified when the updated recording is available. Thank you for your patience!

The drug development process is fraught with complexities and bottlenecks that can slow progress. To make informed decisions, researchers need access to comprehensive, accurate scientific data, especially when uncovering unexpected benefits or adverse effects during exploratory development. However, the adoption of costly, resource-intensive technologies can be a significant hurdle.

This webinar will demonstrate how integrating high-plex proteomics services can help overcome these barriers, accelerating decision-making throughout drug development. Proteomic insights are increasingly shaping every stage of the drug discovery and development pipeline. By analyzing protein and single-cell interactions, we can gain a deeper understanding of disease mechanisms, immune potency and persistence, immune-related adverse events, and immunosuppression.

Join us to learn how leveraging proteomics services—ranging from spatial proteomics to flow cytometry to ultra-high-plex techniques—can de-risk your projects and provide the broadest immune coverage available, maximizing insights and driving faster, more confident evidence-based decisions.

Key Topics:

  • Discover how proven proteomics platforms can help address the challenges of reproducibility, enabling you to obtain consistent, high-quality data over time and across multiple studies.

  • Explore how leveraging Standard BioTools Services allows you to access world-leading proteomics technologies without the need for expensive equipment or specialized in-house expertise enabling you to make breakthroughs in research and accelerate your progress towards impactful solutions.

  • Discover how the integration of advanced tools, such as spatial proteomics and ultra-high-plex techniques, delivers actionable insights, enhances research precision, and reduces risk in your projects.

  • Gain practical knowledge on leveraging proteomics for faster, more confident decision-making, driving efficient and successful outcomes throughout the drug discovery pipeline.

WEBINAR ENDED
Presenters
1743622850-8d0f4d07320e4ea1
Stephen A. Williams, M.D., Ph.D
Chief Medical Officer
Stephen Williams, M.D., Ph.D. has been the Chief Medical Officer at SomaLogic since 2009, and is responsible for Clinical R&D, Medical Affairs and Regulatory and Quality. He oversees clinical application of the SomaScan® Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.

Dr. Williams previously had an 18-year career at Pfizer, Inc., with multiple roles in Experimental Medicine and as the Vice President and Worldwide Head of Clinical Technology. He was also on the National Advisory Council for Biomedical Imaging and Bioengineering at the U.S. National Institutes of Health. He helped launch the Alzheimer’s Disease Neuroimaging (ADNI) study and form the FDA-FNIH-PhRMA biomarker consortium.

Dr. Williams has degrees in physiology, medicine and surgery, and received his doctorate in medicine and physiology from Charing Cross and Westminster Medical School (now a part of Imperial College, London). He also obtained training in diagnostic imaging at the University of Newcastle Upon Tyne.
1743622911-274dfef713a68630
Nina Lane, Ph.D.
Product Manager for CyTOF/IMC Service Lab
Nina Lane, Ph.D., has been at Standard BioTools since 2016. She started her industry career as a Field applications specialist within EMEA. After 4 years and relocating to Canada, she worked as a Product applications specialist before becoming a Product Manager in 2021. She is responsible for CyTOF/IMC studies, managing a busy service lab, and executing bioinformatics services. Over the last 9 years, she has worked with Academics, pharmaceuticals, and Biotechs on a variety of studies, from Pre-clinical to Phase 2 studies.

Dr. Lane was previously a Senior Scientific Officer at Cancer Research UK. Before Joining CRUK, she was Head of the Flow Cytometry core facility at the University of Nottingham after she completed her degree in Biomedical Science and Immunology and Allergy.
Register To Watch Recording
First Name*
Last Name*
Email Address*
Organization / Company*
Job Title*
Organization Type*
Country / Region*
Would you like to receive information about Standard BioTools new products, events and publications?*
Yes
No
utm_bmcr_source
Registration Terms
This event is hosted by Scientist.com. By registering and participating, you acknowledge that your personal data will be processed by Scientist.com. You also agree to receive email communication from Scientist.com about this webinar and other programs of similar nature. The sponsor of this webinar is Standard BioTools; by registering and participating, you acknowledge that your data will be processed in accordance with Standard BioTools’ Privacy Policy. You will receive email communication from Standard BioTools about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
Scientist.com Privacy Policy
✓ Yes, I consent to the registration terms.*
Standard BioTools Privacy Policy
✓ Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker